+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Assisted Reproductive Technology Market Size, Share & Trends Analysis Report by Type (IVF, Artificial Insemination), by End-use (Fertility Clinics & Other Facilities, Hospitals & Other Settings), by Region, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 100 Pages
  • August 2022
  • Region: Global
  • Grand View Research
  • ID: 4582087
The global assisted reproductive technology market size is expected to reach USD 41.4 billion by 2030, according to this report. It is expected to register a CAGR of 6.15% during the forecast period. The growth of the market is mainly driven by the rising cases of infertility globally. In addition, the growing awareness about infertility and treatment methods available to conceive a child is expected to boost the industry growth during the forecast period. The rising adoption of Assisted Reproductive Technologies (ART) by couples and prospective parents trying for children is expected to boost the industry's growth.

Furthermore, the increasing use of technologies in ART, such as Artificial Intelligence (AI) and Machine learning (ML), for research and development is expected to improve patient outcomes. For instance, as per the article published in the National Library of Medicine, Preimplantation genetic testing for aneuploidies (PGT-A), when coupled with IVF, showed positive results in reversal of the effect of maternal age on the rates of implantation and also a decrease in miscarriage rates were shown in the study, especially for frozen transfers.

The COVID-19 pandemic adversely affected the industry owing to the cancellation and postponed procedures and a reduction of patient visits to fertility clinics. It adversely affected the mental health of the couples undergoing ART due to the cancellation of the procedures for IVF and artificial insemination. The market is now slowly regaining to the pre-pandemic rates due to relaxation in the restrictions. Key companies operating in the market are adopting various strategies to gain higher market share, such as mergers and acquisitions. For instance, in January 2019, Ferrings Pharmaceuticals acquired the U.S. commercialization rights for the Ganirelix Acetate injection generic from Sun Pharma and expands its reproductive medicine portfolio to provide resources and services for ART.

Assisted Reproductive Technology Market Report Highlights

  • Based on the type, the IVF segment dominated the market in 2021 due to innovations in IVF including cryopreservation of excess embryos and sperm, Preimplantation Genetic Diagnosis (PGD) with the aid of chromosomal screening, and others that would not be possible without IVF
  • The artificial insemination segment is expected to witness the fastest CAGR from 2022 to 2030 due to the less invasive technique and involvement of fewer medicines than the IVF
  • Based on end-uses, the fertility clinics & other settings segment held the largest revenue share in 2021 due to factors, such as increased precision and availability of specialized treatment
  • Europe held the largest revenue share in 2021 owing to factors, such as the growing infertility cases and awareness programs for the treatment & detection of infertility
  • North America is expected to witness the fastest growth rate from 2022 to 2030 due to the initiatives taken by the government and competent authorities including the American Society for Reproductive Medicine, and Society for Assisted Reproductive Society (SART)

Table of Contents

Chapter 1 Report Scope and Objectives
1.1 Market Segmentation
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Research Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
Chapter 2 Methodology
2.1 Research Methodology
2.1.1 Information procurement
2.1.2 Purchased Database
2.1.3 Internal Database
2.1.4 Secondary Sources
2.1.5 Primary Research
2.2 Information or Data Analysis
2.2.1 Data Analysis Models
2.3 Market Formulation & Validation
2.4 Model Details
2.4.1 Commodity Flow Analysis
2.4.2 Volume price analysis
2.5 List of Secondary Sources
2.6 List of Abbreviations
Chapter 3 Executive Summary
3.1 Market Outlook
3.2 Segment Outlook
3.2.1 Type
3.2.2 End-use
3.3 Regional Outlook
3.4 Competitive Insights
Chapter 4 Market Variables, Trends & Scope
4.1 Market Lineage Outlook
4.1.1 Parent Market Outlook
4.1.2 Related/Ancillary Market Outlook
4.2 Assisted Reproductive Technology Market Dynamics
4.2.1 Market Driver Analysis
4.2.1.1 Constant rise in infertility rates
4.2.1.2 Growing awareness and social acceptance of assisted reproductive technologies
4.5.1.3 Increasing number of single women and same-sex couples
4.2.2 Market Restraint Analysis
4.2.2.1 Changing government regulations
4.3 Assisted Reproductive Technology Market: Business Environment Analysis Tools
4.3.1 Porter’s five forces analysis
4.3.2 PESTLE Analysis
4.3.2.1 Political & Legal
4.3.2.2 Economic & Social
4.3.2.3 Technological
4.4 Penetration & Growth Prospect Mapping
4.5 Qualitative Analysis: Impact of COVID-19 on Assisted Reproductive Technology Market
Chapter 5 Assisted Reproductive Technology Market: Type Analysis
5.1 Assisted Reproductive Technology Type Market Share Analysis, 2021 & 2030
5.2 Assisted Reproductive Technology Type Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, 2017 - 2030 for the Type Segment
5.3.1 In-Vitro Fertilization (IVF)
5.3.1.1 In-Vitro Fertilization (IVF) market, 2017 - 2030 (USD Million)
5.3.1.2 Fresh Donor
5.3.1.2.1 Fresh Donor market, 2017 - 2030 (USD Million)
5.3.1.3 Frozen Donor
5.3.1.3.1 Frozen Donor market, 2017 - 2030 (USD Million)
5.3.1.4 Fresh Non-donor
5.3.1.4.1 Fresh Non-donor market, 2017 - 2030 (USD Million)
5.3.1.5 Frozen Non-donor
5.3.1.5.1 Frozen Non-donor market, 2017 - 2030 (USD Million)
5.3.2 Artificial Insemination
5.3.2.1 Artificial insemination market, 2017 - 2030 (USD Million)
5.3.2.2 Intrauterine Insemination
5.3.2.2.1 Intrauterine insemination market, 2017 - 2030 (USD Million)
5.3.2.3 Intracervical Insemination
5.3.2.3.1 Intracervical insemination market, 2017 - 2030 (USD Million)
5.3.2.4 Intravaginal Insemination
5.3.2.4.1 Intravaginal insemination market, 2017 - 2030 (USD Million)
5.3.2.5 Intratubal Insemination
5.3.2.5.1 Intratubal insemination market, 2017 - 2030 (USD Million)
Chapter 6 Assisted Reproductive Technology Market: End-use Analysis
6.1 Assisted Reproductive Technology End-use Market Share Analysis, 2021 & 2030
6.2 Assisted Reproductive Technology End-use Market: Segment Dashboard
6.3 Market Size & Forecasts and Trend Analyses, 2017 - 2030 for the End-use Segment
6.3.1 Fertility Clinics & Other Facilities
6.3.1.1 Fertility Clinics & other facilities market, 2017 - 2030 (USD Million)
6.3.2 Hospitals & Other Settings
6.3.2.1 Hospitals & other settings market, 2017 - 2030 (USD Million)
Chapter 7 Assisted Reproductive Technology Market: Regional Analysis
7.1 Assisted Reproductive Technology Regional Market Share Analysis, 2021 & 2030
7.2 Regional Market Snapshot
7.3 Market Size, & Forecasts and Trend Analysis, 2017 to 2030
7.3.1 North America
7.3.1.1 North America assisted reproductive technology market, 2017 - 2030 (USD Million)
7.3.1.2 U.S.
7.3.1.2.1 U.S. assisted reproductive technology market, 2017 - 2030 (USD Million)
7.3.1.3 Canada
7.3.1.3.1 Canada assisted reproductive technology market, 2017 - 2030 (USD Million)
7.3.2 Europe
7.3.2.1 Europe assisted reproductive technology market, 2017 - 2030 (USD Million)
7.3.2.2 U.K.
7.3.2.2.1 U.K. assisted reproductive technology market, 2017 - 2030 (USD Million)
7.3.2.3 Germany
7.3.2.3.1 Germany assisted reproductive technology market, 2017 - 2030 (USD Million)
7.3.2.4 France
7.3.2.4.1 France assisted reproductive technology market, 2017 - 2030 (USD Million)
7.3.2.5 Italy
7.3.2.5.1 Italy assisted reproductive technology market, 2017 - 2030 (USD Million)
7.3.2.6 Spain
7.3.2.6.1 Spain assisted reproductive technology market, 2017 - 2030 (USD Million)
7.3.3 Asia Pacific
7.3.3.1 Asia Pacific assisted reproductive technology market, 2017 - 2030 (USD Million)
7.3.3.2 Japan
7.3.3.2.1 Japan assisted reproductive technology market, 2017 - 2030 (USD Million)
7.3.3.3 China
7.3.3.3.1 China assisted reproductive technology market, 2017 - 2030 (USD Million)
7.3.3.4 India
7.3.3.4.1 India assisted reproductive technology market, 2017 - 2030 (USD Million)
7.3.4 Latin America
7.3.4.1 Latin America assisted reproductive technology market, 2017 - 2030 (USD Million)
7.3.4.2 Mexico
7.3.4.2.1 Mexico assisted reproductive technology market, 2017 - 2030 (USD Million)
7.3.4.3 Brazil
7.3.4.3.1 Brazil assisted reproductive technology market, 2017 - 2030 (USD Million)
7.3.5 Middle East & Africa
7.3.5.1 Middle East & Africa assisted reproductive technology market, 2017 - 2030 (USD Million)
7.3.5.2 South Africa
7.3.5.2.1 South Africa assisted reproductive technology market, 2017 - 2030 (USD Million)
Chapter 8 Competitive Analysis
8.1 Recent Developments & Impact Analysis, by Key Market Participants
8.2 Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
8.3 Company Market Position Analysis
8.4 Company Profiles
8.4.1 Cosmos Biomedical Ltd.
8.4.1.1 Company overview
8.4.1.2 Financial performance
8.4.1.3 Product benchmarking
8.4.1.4 Strategic initiatives
8.4.2 Microm U.K. Ltd.
8.4.2.1 Company overview
8.4.2.2 Financial performance
8.4.2.3 Product benchmarking
8.4.2.4 Strategic initiatives
8.4.3 CooperSurgical Inc.
8.4.3.1 Company overview
8.4.3.2 Financial performance
8.4.3.3 Product benchmarking
8.4.3.4 Strategic initiatives
8.4.4 FUJIFILM IrvineScientific
8.4.4.1 Company overview
8.4.4.2 Financial performance
8.4.4.3 Product benchmarking
8.4.3.4 Strategic initiatives
8.4.5 Cryolab Ltd.
8.4.5.1 Company overview
8.4.5.2 Financial performance
8.4.5.3 Product benchmarking
8.4.5.4 Strategic initiatives
8.4.6 Vitrolife AB
8.4.6.1 Company overview
8.4.6.2 Financial performance
8.4.6.3 Product benchmarking
8.4.6.4 Strategic initiatives
8.4.7 European Sperm Bank
8.4.7.1 Company overview
8.4.7.2 Financial performance
8.4.7.3 Product benchmarking
8.4.7.4 Strategic initiatives
8.4.8 Bloom IVF Centre
8.4.8.1 Company overview
8.4.8.2 Financial performance
8.4.8.3 Product benchmarking
8.4.8.4 Strategic initiatives
8.4.9 Merck KGaA
8.4.9.1 Company overview
8.4.9.2 Financial performance
8.4.9.3 Product benchmarking
8.4.9.4 Strategic initiatives
8.4.10 Ferring B.V.
8.4.10.1 Company overview
8.4.10.2 Financial performance
8.4.10.3 Product benchmarking
8.4.10.4 Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 Comparison of Assisted Reproductive Technology
Table 4 List of players in North America
Table 5 List of players in Europe
Table 6 List of players in the Asia Pacific
Table 7 North America Assisted Reproductive Technology Market, by Country, 2017 - 2030 (USD Million)
Table 8 North America Assisted Reproductive Technology Market, by Type, 2017 - 2030 (USD Million)
Table 9 North America Assisted Reproductive Technology Market, by End-use 2017 - 2030 (USD Million)
Table 10 U.S. Assisted Reproductive Technology Market, by Type, 2017 - 2030 (USD Million)
Table 11 U.S. Assisted Reproductive Technology Market, by End-use 2017 - 2030 (USD Million)
Table 12 Canada Assisted Reproductive Technology market, by Type, 2017 - 2030 (USD Million)
Table 13 Canada Assisted Reproductive Technology market, by End-use 2017 - 2030 (USD Million)
Table 14 Europe Assisted Reproductive Technology Market, by Country, 2017 - 2030 (USD Million)
Table 15 Europe Assisted Reproductive Technology market, by Type, 2017 - 2030 (USD Million)
Table 16 Europe Assisted Reproductive Technology market, by End-use 2017 - 2030 (USD Million)
Table 17 U.K. Assisted Reproductive Technology market, by Type, 2017 - 2030 (USD Million)
Table 18 U.K. Assisted Reproductive Technology market, by End-use 2017 - 2030 (USD Million)
Table 19 France Assisted Reproductive Technology market, by Type, 2017 - 2030 (USD Million)
Table 20 France Assisted Reproductive Technology market, by End-use 2017 - 2030 (USD Million)
Table 21 Germany Assisted Reproductive Technology market, by Type, 2017 - 2030 (USD Million)
Table 22 Germany Assisted Reproductive Technology market, by End-use 2017 - 2030 (USD Million)
Table 23 Italy Assisted Reproductive Technology market, by Type, 2017 - 2030 (USD Million)
Table 24 Italy Assisted Reproductive Technology market, by End-use 2017 - 2030 (USD Million)
Table 25 Spain Assisted Reproductive Technology market, by Type, 2017 - 2030 (USD Million)
Table 26 Spain Assisted Reproductive Technology market, by End-use 2017 - 2030 (USD Million)
Table 27 Asia Pacific Assisted Reproductive Technology market, by Country, 2017 - 2030 (USD Million)
Table 28 Asia Pacific Assisted Reproductive Technology market, by Type, 2017 - 2030 (USD Million)
Table 29 Asia Pacific Assisted Reproductive Technology market, by End-use 2017 - 2030 (USD Million)
Table 30 Japan Assisted Reproductive Technology market, by Type, 2017 - 2030 (USD Million)
Table 31 Japan Assisted Reproductive Technology market, by End-use 2017 - 2030 (USD Million)
Table 32 China Assisted Reproductive Technology market, by Type, 2017 - 2030 (USD Million)
Table 33 China Assisted Reproductive Technology market, by End-use 2017 - 2030 (USD Million)
Table 34 India Assisted Reproductive Technology market, by Type, 2017 - 2030 (USD Million)
Table 35 India Assisted Reproductive Technology market, by End-use 2017 - 2030 (USD Million)
Table 36 Latin America Assisted Reproductive Technology Market, by Country, 2017 - 2030 (USD Million)
Table 37 Latin America Assisted Reproductive Technology market, by Type, 2017 - 2030 (USD Million)
Table 38 Latin America Assisted Reproductive Technology market, by End-use 2017 - 2030 (USD Million)
Table 39 Brazil Assisted Reproductive Technology market, by Type, 2017 - 2030 (USD Million)
Table 40 Brazil Assisted Reproductive Technology market, by End-use 2017 - 2030 (USD Million)
Table 41 Mexico Assisted Reproductive Technology market, by Type, 2017 - 2030 (USD Million)
Table 42 Mexico Assisted Reproductive Technology market, by End-use 2017 - 2030 (USD Million)
Table 43 MEA Assisted Reproductive Technology Market, by Country, 2017 - 2030 (USD Million)
Table 44 MEA Assisted Reproductive Technology market, by Type, 2017 - 2030 (USD Million)
Table 45 MEA Assisted Reproductive Technology market, by End-use 2017 - 2030 (USD Million)
Table 46 South Africa Assisted Reproductive Technology market, by Type, 2017 - 2030 (USD Million)
Table 47 South Africa Assisted Reproductive Technology market, by End-use 2017 - 2030 (USD Million)
List of Figures
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain-based sizing & forecasting
FIG. 6 QFD modeling for market share assessment
FIG. 7 Market formulation & validation
FIG. 8 Market outlook
FIG. 9 Assisted Reproductive Technology market segmentation
FIG. 10 Penetration & growth prospect mapping
FIG. 11 Market trends & outlook
FIG. 12 Market driver relevance analysis (Current & future impact)
FIG. 13 Market restraint relevance analysis (Current & future impact)
FIG. 14 Assisted reproductive technology type market share analysis, 2021 & 2030
FIG. 15 Assisted reproductive technology type market: Segment dashboard
FIG. 16 In-Vitro Fertilization (IVF) market, 2017 - 2030 (USD Million)
FIG. 17 Fresh donor market, 2017 - 2030 (USD Million)
FIG. 18 Frozen donor market, 2017 - 2030 (USD Million)
FIG. 19 Fresh non-donor market, 2017 - 2030 (USD Million)
FIG. 20 Frozen non-donor market, 2017 - 2030 (USD Million)
FIG. 21 Artificial Insemination market, 2017 - 2030 (USD Million)
FIG. 22 Intrauterine Insemination market, 2017 - 2030 (USD Million)
FIG. 23 Intracervical Insemination market, 2017 - 2030 (USD Million)
FIG. 24 Intravaginal Insemination market, 2017 - 2030 (USD Million)
FIG. 25 Intratubal Insemination market, 2017 - 2030 (USD Million)
FIG. 26 Assisted reproductive technology end-use market share analysis, 2021 & 2030
FIG. 27 Assisted reproductive technology end-use market: Segment dashboard
FIG. 28 Fertility clinics & other settings market, 2017 - 2030 (USD Million)
FIG. 29 Hospitals and others market, 2017 - 2030 (USD Million)
FIG. 30 Assisted reproductive technology regional market share analysis, 2021 & 2030
FIG. 31 Assisted reproductive technology regional market: Segment dashboard
FIG. 32 Regional marketplace: Key takeaways
FIG. 33 North America assisted reproductive technology market, 2017 - 2030 (USD Million)
FIG. 34 U.S. assisted reproductive technology market, 2017 - 2030 (USD Million)
FIG. 35 Canada assisted reproductive technology market, 2017 - 2030 (USD Million)
FIG. 36 Europe assisted reproductive technology market, 2017 - 2030 (USD Million)
FIG. 37 U.K. assisted reproductive technology market, 2017 - 2030 (USD Million)
FIG. 38 France assisted reproductive technology market, 2017 - 2030 (USD Million)
FIG. 39 Germany assisted reproductive technology market, 2017 - 2030 (USD Million)
FIG. 40 Italy assisted reproductive technology market, 2017 - 2030 (USD Million)
FIG. 41 Spain assisted reproductive technology market, 2017 - 2030 (USD Million)
FIG. 42 Asia Pacific assisted reproductive technology market, 2017 - 2030 (USD Million)
FIG. 43 Japan assisted reproductive technology market, 2017 - 2030 (USD Million)
FIG. 44 China assisted reproductive technology market, 2017 - 2030 (USD Million)
FIG. 45 India assisted reproductive technology market, 2017 - 2030 (USD Million)
FIG. 46 Latin America assisted reproductive technology market, 2017 - 2030 (USD Million)
FIG. 47 Brazil assisted reproductive technology market, 2017 - 2030 (USD Million)
FIG. 48 Mexico assisted reproductive technology market, 2017 - 2030 (USD Million)
FIG. 49 MEA assisted reproductive technology market, 2017 - 2030 (USD Million)
FIG. 50 South Africa assisted reproductive technology market, 2017 - 2030 (USD Million)
FIG. 51 Recent developments & impact analysis, by key market participants
FIG. 52 Company categorization analysis
FIG. 53 Company market position analysis

Companies Mentioned

  • Cosmos Biomedical Ltd.
  • Microm U.K. Ltd.
  • CooperSurgical Inc.
  • FUJIFILM IrvineScientific
  • Cryolab Ltd.
  • Vitrolife AB
  • European Sperm Bank
  • Bloom IVF Centre
  • Merck KGaA
  • Ferring B.V.

Methodology

Loading
LOADING...

Table Information